What happened: Following a fatal meningitis B outbreak in Kent, experts are reviewing whether to offer the vaccine to a broader group of people. The Joint Committee on Vaccination and Immunisation is reassessing current eligibility criteria at the request of the health secretary.
Why it matters:
- Potentially increases protection against meningitis B for more individuals.
- Could help prevent future outbreaks and reduce fatalities in affected communities.
MNN Take: The review aims to determine if extending vaccine access could improve public health outcomes. Decisions will be based on scientific evidence and the outbreak’s impact.
Sources: Guardian UK